Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Comment by blogon Jan 29, 2011 7:10pm
387 Views
Post# 18046119

RE: RE: RE: This Is Major News!

RE: RE: RE: This Is Major News!

>That I cannot help you with

It’s probably a good thing, as help from you can sound like help from a dingbat.

It could be inferred from a pervious post of yours it’s not worth going for drug approval in North America because it’s less that 5% of the world market? This was done in the context of market worth. And again, it could be inferred from your post China is where most of the 3 - 4 billion calcineurin inhibitor market is coming from currently. Teevee makes more sense than you.

<< Previous
Bullboard Posts
Next >>